查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1961410

女性應力性尿失禁治療設備市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、最終用戶、地區和競爭對手分類，2021-2031年

Female Stress Urinary Incontinence Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End-user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球女性應力性尿失禁(SUI) 治療設備市場預計將從 2025 年的 7.8303 億美元成長到 2031 年的 12.0913 億美元，複合年成長率為 7.51%。

陰道托、尿道隔膜吊帶和尿道填充物等專業醫療產品旨在透過加強膀胱頸或改善運動時的尿道閉合功能來恢復尿失禁。該領域的成長主要受人口結構變化所驅動，尤其是老年女性數量的增加和肥胖率的上升，這兩者都是骨盆底肌肉無力的主要風險因素。此外，微創手術方式的日益普及以及患者對有效治療策略的教育加強也推動了市場的發展。

市場概覽
預測期 2027-2031
市場規模：2025年 7.8303億美元
市場規模：2031年 12.0913億美元
複合年成長率：2026-2031年 7.51%
成長最快的細分市場 尿道吊帶
最大的市場 北美洲

這種強勁的需求也體現在其高發病率上，凸顯了臨床解決方案的迫切性。根據2025年版《美國泌尿外科協會新聞》（AUANews）的報道，「應力性尿失禁是最常見的尿失禁類型，在積極參與體育鍛煉的女性中，其患病率超過40%。」儘管市場前景光明，但由於嚴格的監管標準以及關於經陰道網植入安全性的持續訴訟，該市場面臨著諸多挑戰。這些問題不斷削弱人們對外科醫師的信心，並降低患者接受網片植入手術的意願。

市場促進因素

女性應力性尿失禁(SUI) 發生率的不斷上升是推動該醫療器材市場發展的主要動力，在全球範圍內擴大了臨床需求。生活方式因素和女性人口老化加劇了這種人口壓力，促使人們尋求更廣泛的治療性介入。此疾病的龐大規模迫使醫療服務提供者專注於可擴展的解決方案，從尿道填充劑到先進的外科植入。為了應對這一廣泛的負擔，UroMems 公司在 2024 年 6 月宣布：“UroMems 完成創紀錄的 4700 萬美元 C 輪資金籌措”，應力性尿失禁影響著約 4000 萬美國人和 9000 萬歐洲人。如此龐大的患者群體強烈表明，需要有效的管理策略，而這需要醫療專業人員的統計數據支持。根據國際尿控協會的數據，到 2024 年，工作年齡層專業女性的尿失禁盛行率將超過 25%，這表明該疾病正在從老年人蔓延到活躍人群。

同時，智慧穿戴技術的引進正以其非侵入式、居家式的替代方案改變著市場格局。隨著患者越來越傾向於選擇更隱密、更便捷的治療方案而非手術，製造商正將數位連接和生物回饋療法機制整合到骨盆底肌訓練設備中，以改善臨床療效和提高治療依從性。這種向數位化療法的轉變彌補了傳統保守治療的不足，提供了進展追蹤和即時視覺化功能。 Axena Health 於 2024 年 7 月發布的題為《Axena Health 發布新的真實世界證據，進一步增強 Leva 骨盆底健康系統》的報告證實了這些現代方法的有效性，其中 74% 的參與者在使用該系統後症狀得到改善。這些創新不僅提高了患者的生活品質，也促進了基於設備的治療方法作為一線標準治療方案的廣泛接受。

市場挑戰

嚴格的監管標準和持續不斷的關於經陰道網植入安全性的訴訟，是全球女性應力性尿失禁（SUI）治療器械市場發展的主要障礙。這種複雜的市場情況削弱了外科醫生的信心，並因擔心面臨巨額賠償訴訟而阻礙了製造商積極研發產品，從而抑制了市場成長。隨著監管審查的加強以及醫療設備認證對更可靠的臨床數據的需求，企業面臨更高的合規成本和更長的上市週期。因此，這些法律法規的變化正在改變臨床實踐模式，導致許多醫療機構優先考慮保守治療策略，並減少使用網路醫療設備。

近期產業數據顯示，安全隱患正在產生持久影響，這也印證了手術數量的下降趨勢。據美國泌尿系統協會稱，「在所分析的人群中，壓力性尿失禁患者接受吊帶手術的比例將持續下降，到2024年約為2.0%。」這一趨勢表明，儘管壓力性尿失禁十分普遍，但對法律影響和監管障礙的擔憂確實限制了市場規模，並抑制了患者對該設備的接受度。

市場趨勢

高強度聚焦電磁（HIFEM）椅式療法的興起正日益重塑市場格局，它提供了一種完全被動、非侵入性的治療選擇，與主動式物理治療截然不同。傳統的保守治療和生物回饋療法系統依賴患者的依從性和努力，而HIFEM技術則利用電磁能量，在一次住院治療中即可產生數千次超強骨盆底肌收縮。這確保了治療效果的持續性，且不會對患者造成身體負擔。這項技術正迅速獲得商業性認可，因為它滿足了臨床醫生對有效、零恢復期解決方案的需求，尤其適用於那些對手術猶豫不決或難以堅持自主運動的患者。為了佐證這一成長，《美容醫學從業者》雜誌2024年12月刊發表了報導，報道稱BTL Aesthetics僅在亞太地區就安裝了超過500台Emsella設備，凸顯了這種椅式療法在全球範圍內受到醫療保健機構的廣泛關注和支持。

同時，在消費者對非臨床環境下即時、按需緩解症狀的需求日益成長的推動下，一次性非處方（OTC）陰道支撐墊的普及呈現出明顯的趨勢。這些機械裝置能夠為尿道提供隱藏的結構支撐，尤其是在運動期間，有效彌合了永久性手術植入和可吸收墊之間的治療差距，從而幫助女性自主管理自身病情。這一趨勢象徵著醫療保健的民主化，從僵化的處方箋模式轉向易於獲取、患者可自行管理的解決方案，無需長期醫療承諾。例如，根據2025年4月發表在《醫療產品外包》（Medical Product Outsourcing）報導上的一篇文章《Uresta宣佈在美國推出新型膀胱支撐解決方案》，Uresta成功資金籌措了300萬美元，以加速其可重複使用膀胱支撐裝置的商業化進程。這反映了該行業正朝著擴充性的、以消費者為導向的創新方向發展。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：女性應力性尿失禁（SUI）治療器械的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（尿道吊帶、導尿管、陰道托、其他）
    • 按最終使用者（醫院/門診手術中心 (ASC)、專科診所、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美女性應力性尿失禁（SUI）治療器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲女性應力性尿失禁（SUI）治療器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區女性應力性尿失禁（SUI）治療器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲女性應力性尿失禁的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美女性應力性尿失禁（SUI）治療器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球女性應力性尿失禁（SUI）治療設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Coloplast
  • Boston Scientific
  • Cook Medical
  • Axonics
  • Neomedic
  • Mentor
  • Hollister
  • AM Surgical
  • Uroplasty Lines

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 26751

The Global Female Stress Urinary Incontinence (SUI) Devices Market is projected to expand from USD 783.03 Million in 2025 to USD 1209.13 Million by 2031, registering a CAGR of 7.51%. These specialized medical products, which include vaginal pessaries, midurethral slings, and urethral bulking agents, are engineered to restore continence by reinforcing the bladder neck or improving urethral closure during physical activity. Growth in this sector is fundamentally fueled by demographic changes, particularly the increasing population of aging women and rising obesity rates, both of which are major risk factors for pelvic floor weakness. Additionally, the market is being propelled by a growing inclination toward minimally invasive surgical options and enhanced patient education regarding effective management strategies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 783.03 Million
Market Size 2031USD 1209.13 Million
CAGR 2026-20317.51%
Fastest Growing SegmentUrethral Slings
Largest MarketNorth America

This strong demand is reinforced by significant prevalence rates that emphasize the urgent need for clinical solutions. According to 'AUANews' in '2025', 'stress urinary incontinence is the most common type of urinary incontinence with a prevalence of over 40% in females who actively participate in physical activities'. Despite these favorable growth prospects, the market confronts considerable obstacles stemming from strict regulatory standards and persistent litigation concerning the safety of transvaginal mesh implants. These issues continue to undermine surgeon confidence and reduce patient willingness to consent to mesh-based procedures.

Market Driver

The increasing incidence of female stress urinary incontinence (SUI) acts as a primary catalyst for the devices market, generating growing clinical demand worldwide. This demographic strain, heightened by lifestyle factors and an aging female population, requires a wider array of therapeutic interventions. The magnitude of this condition compels healthcare providers to focus on scalable solutions, extending from urethral bulking agents to sophisticated surgical implants. Underscoring this extensive burden, according to UroMems, June 2024, in the 'UroMems Raises Record $47 million in Series C Financing' press release, stress urinary incontinence affects an estimated 40 million Americans and 90 million Europeans. This significant patient population highlights the vital need for effective management strategies, a point further bolstered by workforce statistics; according to the International Continence Society, in 2024, the prevalence of urinary incontinence in working-age professional women is greater than 25%, showing that the condition spans active populations rather than being restricted to the geriatric demographic.

Concurrently, the incorporation of smart and wearable technologies is transforming the market by enabling non-invasive, home-based therapeutic alternatives. As patients increasingly prefer discreet and convenient options over surgery, manufacturers are integrating digital connectivity and biofeedback mechanisms into pelvic floor muscle training devices to improve clinical outcomes and adherence. This movement toward digital therapeutics mitigates the shortcomings of conventional conservative treatments by offering progress tracking and real-time visualization. Confirming the effectiveness of these modern approaches, according to Axena Health, July 2024, in the 'Axena Health shares new publication that adds more real-world evidence for the Leva Pelvic Health System' announcement, 74 percent of participants using the system experienced symptom improvement. Such innovations not only enhance patient quality of life but also promote the broader acceptance of device-based therapies as a standard first-line treatment.

Market Challenge

Rigorous regulatory standards and continuing litigation concerning the safety of transvaginal mesh implants constitute a major barrier to the advancement of the Global Female Stress Urinary Incontinence (SUI) Devices Market. This complicated landscape inhibits growth by undermining surgeon confidence and discouraging manufacturers from pursuing aggressive product development due to the risk of significant liability claims. As regulatory authorities increase scrutiny and necessitate more robust clinical data for device approval, companies encounter rising compliance costs and extended timelines for market entry. Consequently, this volatility in the legal and regulatory sphere has altered clinical practice patterns, leading many healthcare providers to decrease their use of mesh-based devices in favor of conservative management strategies.

This reduction in procedural volume is demonstrated by recent industry data that underscores the enduring effect of these safety concerns. According to the 'American Urological Association', in '2024', 'the percentage of patients with stress urinary incontinence who underwent a sling procedure continued to decline to roughly 2.0% within the analyzed population'. Such trends suggest that the fear of legal repercussions and regulatory obstacles effectively constrains the addressable market, restricting patient adoption of these devices despite the widespread prevalence of the condition.

Market Trends

The rise of High-Intensity Focused Electromagnetic (HIFEM) Chair Therapies is increasingly shaping the market, providing a fully passive, non-invasive treatment option that differs significantly from active physical therapy. In contrast to traditional conservative management or biofeedback systems that depend on patient compliance and effort, HIFEM technology uses electromagnetic energy to generate thousands of supramaximal pelvic floor muscle contractions during a single in-office session, ensuring consistent therapeutic results without physical exertion. This technology is experiencing fast commercial adoption as clinicians aim to provide effective, zero-downtime solutions for patients who are reluctant to undergo surgery or struggle with voluntary exercise routines. Confirming this growth, according to Aesthetic Medical Practitioner, December 2024, in the 'BTL wins Best Non-Invasive Body Shaping Manufacturer' article, BTL Aesthetics reported having installed over 500 Emsella devices across the Asia-Pacific region alone, highlighting the substantial global traction and provider acceptance of this chair-based therapy.

At the same time, there is a distinct movement toward Disposable and Over-the-Counter (OTC) Vaginal Support Inserts, fueled by rising consumer demand for immediate, on-demand symptom management outside of clinical environments. These mechanical devices offer discreet structural support to the urethra specifically during physical activity, effectively bridging the therapeutic divide between permanent surgical implants and absorbent pads for women desiring autonomy in managing their condition. This trend represents a democratization of care, shifting away from strictly prescription-based models toward accessible, patient-controlled solutions that can be acquired and used without long-term medical commitments. Emphasizing the investment interest in this sector, according to Medical Product Outsourcing, April 2025, in the 'Uresta Debuts New Bladder Support Solution in U.S.' article, Uresta secured $3 million in funding to accelerate the commercialization of its reusable bladder support device, mirroring the industry's shift toward scalable, consumer-focused innovations.

Key Market Players

  • Coloplast
  • Boston Scientific
  • Cook Medical
  • Axonics
  • Neomedic
  • Mentor
  • Hollister
  • A.M. Surgical
  • Uroplasty Lines

Report Scope

In this report, the Global Female Stress Urinary Incontinence (SUI) Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Female Stress Urinary Incontinence (SUI) Devices Market, By Product Type

  • Urethral Slings
  • Catheters
  • Vaginal Pessaries
  • Others

Female Stress Urinary Incontinence (SUI) Devices Market, By End-user

  • Hospitals & Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Others

Female Stress Urinary Incontinence (SUI) Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Female Stress Urinary Incontinence (SUI) Devices Market.

Available Customizations:

Global Female Stress Urinary Incontinence (SUI) Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Urethral Slings, Catheters, Vaginal Pessaries, Others)
    • 5.2.2. By End-user (Hospitals & Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End-user
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End-user
    • 6.3.2. Canada Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End-user
    • 6.3.3. Mexico Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End-user

7. Europe Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End-user
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End-user
    • 7.3.2. France Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End-user
    • 7.3.3. United Kingdom Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End-user
    • 7.3.4. Italy Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End-user
    • 7.3.5. Spain Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End-user

8. Asia Pacific Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End-user
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End-user
    • 8.3.2. India Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End-user
    • 8.3.3. Japan Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End-user
    • 8.3.4. South Korea Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End-user
    • 8.3.5. Australia Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End-user

9. Middle East & Africa Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End-user
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End-user
    • 9.3.2. UAE Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End-user
    • 9.3.3. South Africa Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End-user

10. South America Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End-user
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End-user
    • 10.3.2. Colombia Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End-user
    • 10.3.3. Argentina Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End-user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Female Stress Urinary Incontinence (SUI) Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Coloplast
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boston Scientific
  • 15.3. Cook Medical
  • 15.4. Axonics
  • 15.5. Neomedic
  • 15.6. Mentor
  • 15.7. Hollister
  • 15.8. A.M. Surgical
  • 15.9. Uroplasty Lines

16. Strategic Recommendations

17. About Us & Disclaimer